Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2013; 109(04): 759-761
DOI: 10.1160/TH12-06-0431
DOI: 10.1160/TH12-06-0431
Letters to the Editor
The role of the metabolic syndrome in patients with provoked venous thromboembolic events
Authors
Further Information
Publication History
Received:
26 June 2012
Accepted after major revision:
20 January 2012
Publication Date:
22 November 2017 (online)
-
References
- 1 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-1173.
- 2 Tapson VF. Acute pulmonary embolism. N Engl J Med 2008; 358: 1037-1052.
- 3 Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 1163-1174.
- 4 Squizzato A, Brivio L, Appio L. et al. Novel risk factors for venous thromboembolism. Hematol Oncol Clin North Am 2010; 24: 709-716.
- 50 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486-2496.
- 6 Gami AS, Witt BJ, Howard DE. et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414.
- 7 Ageno W, Prandoni P, Romualdi E. et al. The metabolic syndrome and the risk of venous thrombosis. A case control study. J Thromb Haemost 2006; 04: 1914-1918.
- 8 Jang MJ, Choi W, Bang SM. et al. Metabolic Syndrome Is Associated With Venous Thromboembolism in the Korean Population. Atheroscl Thromb Vasc Biol 2009; 29: 311-315.
- 9 Maclure M, Willett WC. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol 1987; 126: 161-169.
- 10 Higgins JP, Thompson SG, Deeks JJ. et al. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557-560.
- 11 Guyatt GH, Oxman AD, Kunz R. et al. GRADE Working Group. What is “quality of evidence” and why is it important to clinicians?. Br Med J 2008; 336: 995-998.
- 12 Gandhi R, Razak F, Tso P. et al. Metabolic syndrome and the incidence of symptomatic deep vein thrombosis following total knee arthroplasty. J Rheumatol 2009; 36: 2298-2301.
- 13 Ambrosetti M, Ageno W, Salerno M. et al. Metabolic syndrome as a risk factor for deep vein thrombosis after acute cardiac conditions. Thromb Res 2007; 120: 815-818.
- 14 Vaya A, Martinez-Triguero ML, Espana F. et al. The metabolic syndrome and its individual components: its association with venous thromboembolism in a Mediterranean population. Metabol Syndr Rel Dis 2011; 09: 197-201.
- 15 Di Minno MN, Tufano A, Ageno W. et al. Identifying high-risk individuals for cardiovascular disease: similarities between venous arterial thrombosis in perspective A 2011 update. Intern Emerg Med 2012; 07: 9-13.
- 16 Dentali F, Squizzato A, Ageno W. The metabolic syndrome as a risk factor for venous and arterial thrombosis. Semin Thromb Hemost 2009; 35: 451-457.
- 17 Steffen LM, Cushman M, Peacock JM. et al. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. J Thromb Haemost 2009; 07: 746-751.
- 18 Borch KH, Braekkan SK, Mathiesen EB. et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study. J Thromb Haemost 2009; 07: 739-745.
- 19 Ridker PM, Danielson E, Fonseca FA. et al. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.